LIMN Liminatus Pharma, Inc.

Nasdaq liminatuspharma.com


$ 1.24 $ -0.08 (-6.35 %)    

Monday, 27-Oct-2025 12:08:52 EDT
QQQ $ 626.77 $ 0.00 (0 %)
DIA $ 474.54 $ -0.25 (-0.05 %)
SPY $ 683.63 $ 0.86 (0.13 %)
TLT $ 91.56 $ 0.25 (0.27 %)
GLD $ 367.26 $ -3.73 (-1.01 %)
$ 1.24
$ 1.26
$ 1.20 x 600
$ 1.24 x 23
$ 1.18 - $ 1.27
$ 1.11 - $ 33.66
348,984
na
28.89M
$ -1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-04-2025 06-30-2025 10-Q
2 05-31-2025 03-31-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. has entered into a Memorandum of Understanding (MOU) to form a research and development consortium with ...

 us-stocks-likely-to-open-higher-sp-500-sees-average-gain-of-61-in-2nd-half-expert-says

U.S. futures rose on Wednesday after a mixed close on Tuesday. Futures of major benchmark indices were trading slightly higher.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION